STE

SEC.gov | Request Rate Threshold Exceeded

U.S. Securities and Exchange Commission

You’ve Exceeded the SEC’s Traffic Limit

Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.

Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.

The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.

For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.

For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.

Reference ID: 0.e618d017.1786364119.c9dfb17f

More Information

Internet Security Policy

By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.

Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).

To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.

If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.

Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.

Note: We do not offer technical support for developing or debugging scripted downloading processes.

EX-99.1

2 ste03312026ex991.htm

EX-99.1

Document

Exhibit 99.1

STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year

•Full year fiscal 2026 revenue from continuing operations increased 9%; constant currency organic revenue growth was 7%

•Full year fiscal 2026 as reported diluted EPS from continuing operations increased to $7.93; adjusted EPS per diluted share increased to $10.17

•Board approves new $1 billion share repurchase program

DUBLIN, IRELAND - (May 11, 2026) - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 fourth quarter and full year ended March 31, 2026. Total revenue from continuing operations for the fourth quarter of fiscal 2026 increased 7% to $1.6 billion compared with $1.5 billion in the fourth quarter of fiscal 2025. Constant currency organic revenue growth from continuing operations grew 5% in the fourth quarter.

Revenue from continuing operations for the full year fiscal 2026 increased 9% to $5.9 billion compared with $5.5 billion in fiscal 2025. Constant currency organic revenue growth from continuing operations grew 7% for fiscal 2026.

“Fiscal 2026 was another record year,” said Dan Carestio, President and CEO of STERIS. “Our diversified Customer base and growth in procedure volumes continue to drive our performance. We appreciate the efforts of our global Associates who continue to put our Customers first. As we look ahead, we are excited for what is to come as we capitalize on our unique ability to help our Customers enable procedural growth, deliver quality outcomes and drive compliance with standardization and optimization.”

Total Company Fourth Quarter and Full Year Results from Continuing Operations

As reported, net income from continuing operations for the fourth quarter was $220.3 million or $2.24 per diluted share, compared with net income of $146.5 million or $1.48 per diluted share in the fourth quarter of fiscal 2025. Adjusted net income for the fourth quarter of fiscal 2026 was $278.3 million or $2.83 per diluted share, compared with the previous year’s fourth quarter of $270.3 million or $2.74 per diluted share.

As reported, net income from continuing operations for the full year fiscal 2026 was $782.3 million or $7.93 per diluted share, compared with net income of $610.1 million or $6.16 per diluted share in fiscal 2025. Adjusted net income for the full year fiscal 2026 was $1.0 billion or $10.17 per diluted share, compared with $913.2 million or $9.22 per diluted share in fiscal 2025.

Fourth Quarter Segment Results

Healthcare revenue as reported grew 7% in the fourth quarter to $1.14 billion compared with $1.06 billion in the fourth quarter of fiscal 2025. This performance reflected 9% improvement in service revenue, 7% growth in consumable revenue, and a 6% increase in capital equipment revenue. Constant currency organic revenue growth was 6%. Healthcare operating income was $283.2 million compared with $279.7 million in last year’s fourth quarter. The increase in operating income was primarily due to improved volume and price, which were significantly offset by tariffs and inflation.

Fiscal 2026 fourth quarter revenue for Applied Sterilization Technologies (AST) increased 6% as reported to $289.2 million compared with $273.9 million in the same period last year. This performance reflected 10% growth in service revenue and a 62% decline in capital equipment revenue. Constant currency organic revenue growth was 2%. Segment operating income was $131.1 million in the fourth quarter of fiscal 2026, compared with operating income of $122.2 million in the same period last year. The operating income increase compared with the prior year primarily reflects improved price, which was partially offset by negative volume from capital equipment declines.

Life Sciences fourth quarter revenue as reported increased 9% to $162.9 million compared with $149.5 million in the fourth quarter of fiscal 2025. This performance reflected 19% growth in capital equipment, 8% growth in service revenue and 5% improvement in consumable revenue. Constant currency organic revenue increased 6%. Reflecting improvement in price and volume, somewhat offset by inflation and tariffs, operating income increased to $70.6 million in the fourth quarter of fiscal 2026 compared with $65.0 million in the prior year’s fourth quarter.

Cash Flow

Net cash provided by operations for fiscal 2026 was $1.34 billion, compared with $1.15 billion in fiscal 2025. Free cash flow for fiscal 2026 was $982.9 million compared with $787.2 million in the prior year period. The increase in free cash flow during the period was driven primarily by improvements in net income, which more than offset the significantly lower contribution from working capital in fiscal 2026 compared with fiscal 2025.

Fiscal 2027 Outlook

For fiscal 2027, the Company expects as reported revenue to increase 7-8%. Based on forward rates through March 31, 2027,

ste-202602040001757898Dublin 2,falseD02 R2962026-02-04353001-38848L2falsefalsefalse00017578982026-02-042026-02-0400017578982025-11-052025-11-050001757898ste:OrdinarySharesMember2026-02-042026-02-040001757898ste:STETwo700SeniorNotesDue2031MemberMember2026-02-042026-02-040001757898ste:Two700SeniorNotesDue2051MemberMember2026-02-042026-02-04

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 4, 2026

STERIS plc (Exact Name of Registrant as Specified in Charter)

Ireland001-38848 98-1455064 (State or other jurisdiction of incorporation or organization)(Commission File Number)(IRS Employer Identification No.)

70 Sir John Rogerson's Quay,Dublin 2,IrelandD02 R296 (Address of principal executive offices)

Registrant’s telephone number, including area code: + 353 1 232 2000

Not Applicable (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered Ordinary Shares, $0.001 par valueSTENew York Stock Exchange 2.700% Senior Notes due 2031STE/31New York Stock Exchange 3.750% Senior Notes due 2051STE/51New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 2.02Results of Operations and Financial Condition.

On February 4, 2026, STERIS plc (the “Company”) issued a press release announcing its financial results for the quarter ended December 31, 2025. A copy of this press release is attached hereto as Exhibit 99.1.

The information contained in this Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished to the Securities and Exchange Commission and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities of that Section. Furthermore, the information contained in this Item 2.02 of this Current Report on Form 8-K shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933.

Item 9.01Financial Statements and Exhibits.

(d) Exhibits:

Exhibit No.  Description 99.1  Press Release issued by STERIS plc on February 4, 2026 announcing financial results for its fiscal 2026 third quarter ending December 31, 2025.

104Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

STERIS plc

By /s/ J. Adam Zangerle Name: J. Adam Zangerle Title: Senior Vice President, General Counsel & Company Secretary

Dated: February 4, 2026